EP Patent
EP2945652B1 — Methods of treating cholangiocarcinoma
Assigned to Foundation Medicine Inc · Expires 2021-07-07 · 5y expired
What this patent protects
Patent listed against Zokinvy.
Drugs covered by this patent
- Zokinvy (LONAFARNIB) · Sentynl Theraps Inc
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.